Potent TLR9-Selective and TLR9/7 Dual Antagonists | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Potent TLR9-Selective and TLR9/7 Dual Antagonists

Implementing Organization

Indian Institute of Chemical Biology (IICB)

About

A series of potent inhibitors of toll-like receptor (TLR) 9 as well as dual antagonists of TLR9 and TLR with potential application in auto-immune disease and metabolic syndrome.

Related Research

Quick Information

Focus Area

Potent TLR9

Status

1

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

N/A

Startup (If Any)

00

No. of Patents

Filed :01

Grant :00